1. 1. Roman, G., Mannich bases in medicinal chemistry and drug design. Eur. J. Med. Chem. 2015, 89, 743 - 816.
2. 2. Sanyal, R.; Kundu, P.; Rychagova, E.; Zhigulin, G.; Ketkov, S.; Ghosh, B.; Chattopadhyay, S. K.; Zangrando, E.; Das, D. Catecholase activity of Mannich-based dinuclear CuII complexes with theoretical modelling: new insight into the solvent role in the catalytic cycle. New J. Chem. 2016, 40, 6623 - 6635.
3. 3. Ayeni, A. O.; Egharevba, G. O. Studies of some morpholine- and methylpiperazin-1-yl Mannich ligands and their Cu(II) and Ni(II) complexes. Ife J. Sci. 2015, 17, 685 - 694.
4. 4. Bharathi, K. S.; Sreedaran, S.; Priya, P. H.; Rahiman, A. K.; Rajesh, K.; Jagadish, L.; Kaviyarasan, V.; Narayanan, V. Synthesis of new unsymmetrical “end-off” phenoxo bridged copper(II), nickel(II) and zinc(II) complexes: spectral, magnetic, electrochemical, catalytic, and antimicrobial studies. J. Coord. Chem. 2009, 62, 1356 - 1372.
5. 5. Cary, J. W.; Lax, A. R.; Flurkey, W. H. Cloning and characterization of cDNAs coding for Vicia faba polyphenol oxidase. Plant Mol. Biol. 1992, 20, 245 - 253.